Last reviewed · How we verify
NCT06564727
Uniportal VATS Resection for Pulmonary Aspergilloma : Evaluation of Prognostic Factors in a Single Center Experience
NA trial testing Uniportal VATS approach in Pulmonary Aspergillosis in 51 participants. Completed in 30 January 2020.
1 January 2020
Quick facts
| Lead sponsor | Hassan II University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 51 |
| Start date | 1 January 2017 |
| Primary completion | 1 January 2020 |
| Estimated completion | 30 January 2020 |
| Sites | 1 location across Morocco |
Drugs / interventions tested
- Uniportal VATS approach
- VATS approach
Conditions studied
- Pulmonary Aspergillosis — all drugs for Pulmonary Aspergillosis →
- Surgery-Complications — all drugs for Surgery-Complications →
- Thoracic Diseases — all drugs for Thoracic Diseases →
Sponsor
Hassan II University
Who can join
Eligibility, any sex, with Pulmonary Aspergillosis or Surgery-Complications. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The objective of this study was to report our experience with U-VATS resection and to evaluate our surgical outcomes with an analysis of postoperative complications. The investigators also estimate the prognostic factors that influence the morbidity and the conversion.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06564727
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Pulmonary Aspergillosis
Currently open trials in the same condition.
- NCT06244979 — iMagIng pulmonaRy Aspergillosis Using Gallium-68-dEferoxamine · Phase 2 · recruiting
- NCT04530799 — Prospective Observational Trial of IAPA · active not recruiting
Other Hassan II University trials
Trials by the same sponsor.
- NCT07170371 — Patient Education and Rheumatoid Arthritis · NA · active not recruiting
- NCT06248593 — Continuous Infusion of Norepinephrine vs Phenylephrine During Spinal Anesthesia for Cesarean Section (INPEACE) · Phase 4 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06564727 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hassan II University
- Last refreshed: 21 August 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06564727.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing